Skip to main content
ENLV
NASDAQ Life Sciences

Enlivex Reports 622% Surge in RAIN Trading Volume to $860M, Projects $33B by 2029

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.211
Mkt Cap
$37.872M
52W Low
$2
52W High
$31.5
52W Position info
11% above low
Off High info
93% below high
Rel. Volume info
3.4× avg
Market data snapshot near publication time

ENLV is trading near its 52-week low of $2 (11% above the low) on elevated volume (3.4× avg).

Summary

Enlivex reported $860 million in July trading volume on the Rain protocol, up 622% month-over-month, and provided multi-year volume and fee targets that signal rapid ecosystem growth.


Key Events · Earnings and Guidance · ENLV

  • RAIN Volume Hits $860M in July

    Trading volume on the Rain protocol reached $860 million in July 2026, a 622% increase over June 2026, according to data from the Rain Foundation.

  • Multi-Year Volume Targets Set

    The Rain Foundation projects trading volumes of $1.3B (2027), $12B (2028), and $33B (2029), with gross fees of $49M, $436M, and $1.2B respectively.

  • Buy-and-Burn Fees to Support Token

    Net fees allocated to buy-and-burn the RAIN token are projected at $24M (2027), $216M (2028), and $600M (2029), creating direct demand for the asset.

  • Treasury Value Tied to Protocol Growth

    Enlivex's RAIN token treasury was last valued at ~$1.14B (June 20); accelerating protocol usage and fee-based buybacks could materially increase that value.


Analysis · ENLV · Life Sciences

Enlivex disclosed that trading volume on its core treasury asset, the Rain protocol, hit $860 million in July — a 622% jump from June. The Rain Foundation also laid out aggressive targets: $1.3 billion in 2027, $12 billion in 2028, and $33 billion in 2029, with corresponding buy-and-burn fees that would directly support the RAIN token price. For a company whose market cap is dwarfed by its $1.14 billion RAIN treasury, accelerating protocol usage is a direct driver of asset value and, by extension, shareholder equity. The projections, if realized, would transform the treasury's cash-flow potential.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ENLV was trading at $2.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $37.9M. The 52-week trading range was $2.00 to $31.50. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ENLV - Latest Insights

ENLV
Nov 02, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.90
Real-time Price: $1.19 info
Change: -$0.710 (-37%) info
Market Cap: $1.823M info
ENLV
Oct 27, 2026, 8:59 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $0.1722
Real-time Price: $1.19 info
Change: Reverse Stock Split info
Market Cap: $1.823M info
ENLV
Oct 27, 2026, 8:01 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.1722
Real-time Price: $1.19 info
Change: Reverse Stock Split info
Market Cap: $1.823M info
ENLV
Oct 22, 2026, 5:17 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.59
Real-time Price: $1.19 info
Change: Reverse Stock Split info
Market Cap: $1.823M info
ENLV
Oct 19, 2026, 8:18 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.215914
Real-time Price: $1.19 info
Change: Reverse Stock Split info
Market Cap: $1.823M info